Skip to content

13F-HR filed by HealthCor Management, L.P.

HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 50 holding rows worth $2,386,913,000.

Accession
0001343781-20-000006
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 50 entries on the cover page, a total value of $2,386,913,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,386,913,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AURINIA PHARMACEUTICALS INC COM05156V102Stock9,501,398$154,398,000thousands by filing date
BECTON DICKINSON & CO075887109COM606,470$145,110,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock1,197,884$135,660,000thousands by filing date
AbbVie,Inc.00287Y109COM1,317,570$129,359,000thousands by filing date
NEVRO CORP64157F103COM1,054,103$125,934,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW554,010$92,027,000thousands by filing date
Cigna Corporation125523100COM472,360$88,638,000thousands by filing date
Medtronic PlcG5960L103COM915,440$83,946,000thousands by filing date
HCA Healthcare Inc40412C101COM801,290$77,773,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock544,790$77,295,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock1,246,419$77,191,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM666,510$74,809,000thousands by filing date
LIVANOVA PLCG5509L101SHS1,445,500$69,572,000thousands by filing date
UnitedHealth Group Inc91324P102COM229,650$67,735,000thousands by filing date
Danaher Corporation235851102COM376,665$66,606,000thousands by filing date
Bristol-Myers Squibb Company110122108COM1,062,500$62,475,000thousands by filing date
Amgen Inc.031162100COM259,200$61,135,000thousands by filing date
Abbott Laboratories002824100COM638,180$58,349,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock718,840$58,319,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM743,018$57,955,000thousands by filing date
PEDIATRIX MEDICAL GROUP INC58502B106COM3,387,965$57,934,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM152,180$55,141,000thousands by filing date
NUVASIVE INC670704105COM969,580$53,967,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM1,025,000$49,682,000thousands by filing date
ROYALTY PHARMA PLCG7709Q104SHS CLASS A916,350$44,489,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM355,770$43,404,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock56,550$35,267,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR503,920$33,632,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW480,460$30,245,000thousands by filing date
HUMANA INC COM444859102Stock69,550$26,968,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock198,350$23,675,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS401,040$22,290,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock405,040$21,252,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM100,730$17,562,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock345,370$16,709,000thousands by filing date
BLUEBIRD BIO INC09609G100COM260,700$15,913,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock49,290$13,527,000thousands by filing date
Merck & Co.,Inc.58933Y105COM172,310$13,325,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM25,620$7,438,000thousands by filing date
RTI BIOLOGICS INC74975N105COM2,158,644$6,864,000thousands by filing date
SmileDirectClub Inc83192H106COM700,000$5,530,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK1,200,000$5,520,000thousands by filing date
ARCTURUS THERAPEUTICS HLDGS03969T109COM94,200$4,403,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/99991,115,000$3,992,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS75,000$3,192,000thousands by filing date
FUSION PHARMACEUTICALS INC36118A100COM150,000$2,621,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock128,239$2,322,000thousands by filing date
AKOUOS INC00973J101COM100,000$2,250,000thousands by filing date
GENERATION BIO CO37148K100COM100,000$2,100,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock50,000$1,413,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001343781-20-000006this filing2020-08-14acceptance time not in the bulk data set